Clinical Studies of Risperidone in Korea.
- Author:
Jun Soo KWON
1
;
Tae Hyon HA
Author Information
1. Department of Psychiatry, Seoul National University Hospital, Seoul, Korea.
- Publication Type:Review ; Clinical Trial
- Keywords:
Risperidone;
Clinical studies;
Korea
- MeSH:
Korea*;
Outcome Assessment (Health Care);
Risperidone*
- From:Korean Journal of Psychopharmacology
2003;14(Suppl):128-139
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
There have been 91 papers on risperidone in Korea, which were composed of 21 reviews, 9 preclinical studies, 18 case reports, and 43 clinical trials, since this new antipsychotic was introduced. Case reports focused mainly on adverse effects of risperidone, and clinical trials on it's efficacy and safety. Review of Korean clinical trials revealed the paucity of well designed controlled studies which examined the effective dose and compared the efficacy of risperidone with those of other drugs. Future research should adopt more reliable and standardized methods. The efficacy of risperidone for various clinical populations needs to be elucidated. Researchers need to make an effort to implicate the clinical use of risperidone. Long-term outcome studies are expected.
